Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rotavirus injury compensation

Executive Summary

Public hearing is planned to discuss HHS' proposal to add "vaccines containing live, oral rhesus-based rotavirus" to the National Vaccine Injury Compensation Program's vaccine injury table as a distinct category, with intussusception listed as a covered injury. The hearing will occur in conjunction with the Advisory Commission on Childhood Vaccines' next meeting, scheduled for early December in FDA's Parklawn Building in Rockville, Md. The notice of proposed rulemaking, published in the Federal Register July 13, would cover intussusception cases that "have an onset interval of 30 days"
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS038192

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel